Northwest Biotherapeutics Inc (NWBO)
0.46
-0.01
(-1.27%)
USD |
OTCM |
May 03, 16:00
Northwest Biotherapeutics 1 Year Total Returns (Daily): -23.33% for May 3, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
May 03, 2024 | -23.33% |
May 02, 2024 | -9.74% |
May 01, 2024 | -8.02% |
April 30, 2024 | -7.00% |
April 29, 2024 | -5.44% |
April 26, 2024 | -2.02% |
April 25, 2024 | -4.62% |
April 24, 2024 | -10.22% |
April 23, 2024 | -5.58% |
April 22, 2024 | -3.98% |
April 19, 2024 | -7.69% |
April 18, 2024 | -7.56% |
April 17, 2024 | -7.42% |
April 16, 2024 | -5.69% |
April 15, 2024 | -6.34% |
April 12, 2024 | -12.16% |
April 11, 2024 | -13.93% |
April 10, 2024 | -13.68% |
April 09, 2024 | -11.90% |
April 08, 2024 | -10.77% |
April 05, 2024 | -10.27% |
April 04, 2024 | -9.56% |
April 03, 2024 | -8.83% |
April 02, 2024 | -12.48% |
April 01, 2024 | -16.72% |
Date | Value |
---|---|
March 28, 2024 | -16.96% |
March 27, 2024 | -4.76% |
March 26, 2024 | -17.03% |
March 25, 2024 | -19.84% |
March 22, 2024 | -24.54% |
March 21, 2024 | -23.59% |
March 20, 2024 | -15.28% |
March 19, 2024 | -14.40% |
March 18, 2024 | -12.20% |
March 15, 2024 | -9.41% |
March 14, 2024 | -13.09% |
March 13, 2024 | -12.24% |
March 12, 2024 | -6.67% |
March 11, 2024 | -7.67% |
March 08, 2024 | -13.44% |
March 07, 2024 | -12.86% |
March 06, 2024 | -12.62% |
March 05, 2024 | -15.20% |
March 04, 2024 | -12.45% |
March 01, 2024 | -10.98% |
February 29, 2024 | -16.34% |
February 28, 2024 | -17.54% |
February 27, 2024 | -18.75% |
February 26, 2024 | -20.39% |
February 23, 2024 | -15.28% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-70.67%
Minimum
May 08 2023
1.05K%
Maximum
May 17 2021
91.40%
Average
-8.23%
Median
May 17 2023
1 Year Total Returns (Daily) Benchmarks
NovaBay Pharmaceuticals Inc | -90.79% |
Palatin Technologies Inc | -3.65% |
iBio Inc | -90.87% |
Theriva Biologics Inc | -37.06% |
Oragenics Inc | -59.32% |